Our finding of upregulated GLP1 response in insulin-resistant mice therefore suggests that the metabolic perturbations due to IGT or diabetes compromise the GLP1 effect resulting in reduced responsiveness in these conditions. The gene discussed is GCG; the disease is diabetes mellitus.